| Date | Time | Source | Headline | Symbol | Company |
| 14/02/2019 | 22:43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 17/04/2018 | 06:08 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 16/03/2018 | 23:02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 10/03/2018 | 02:52 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 08/03/2018 | 10:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:24 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 07/03/2018 | 00:02 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 00:19 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 00:13 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 00:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 00:02 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 06/03/2018 | 00:02 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |